|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 141.23 USD | -2.83% |
|
+0.81% | -13.81% |
| 07-29 | Repligen's Diversity of Growth Drivers Support Return to Mid-Teens Organic Sales Growth, RBC Says | MT |
| 07-29 | RBC Raises Price Target on Repligen to $185 From $160, Keeps Outperform Rating | MT |
Company Valuation: Repligen Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,643 | 9,401 | 10,039 | 8,064 | 9,224 | 7,970 | - | - |
| Change | - | -35.8% | 6.78% | -19.67% | 14.38% | -13.59% | - | - |
| Enterprise Value (EV) 1 | 14,405 | 9,062 | 9,357 | 7,833 | 9,200 | 7,771 | 7,587 | 7,363 |
| Change | - | -37.09% | 3.26% | -16.29% | 17.46% | -15.53% | -2.37% | -2.96% |
| P/E | 118x | 52.3x | 243x | -313x | 191x | 185x | 80.1x | 57x |
| PBR | 8.67x | 4.92x | 5.09x | 4.09x | 4.38x | 3.67x | 3.41x | 3.09x |
| PEG | - | 1.2x | -3.1x | 2x | -1x | -16.7x | 1x | 1.4x |
| Capitalization / Revenue | 21.8x | 11.7x | 15.7x | 12.7x | 12.5x | 9.64x | 8.23x | 7.02x |
| EV / Revenue | 21.5x | 11.3x | 14.6x | 12.3x | 12.5x | 9.4x | 7.83x | 6.48x |
| EV / EBITDA | 62.5x | 36.7x | 73.1x | 66.8x | 65.6x | 45.6x | 34.3x | 25.7x |
| EV / EBIT | 66.9x | 39x | 99.2x | 95.4x | 90.4x | 59.6x | 43.8x | 31.9x |
| EV / FCF | 277x | 104x | 120x | 52.3x | 98x | 64.8x | 51.8x | 37x |
| FCF Yield | 0.36% | 0.96% | 0.83% | 1.91% | 1.02% | 1.54% | 1.93% | 2.71% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.24 | 3.24 | 0.74 | -0.46 | 0.86 | 0.765 | 1.762 | 2.479 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 670.5 | 801.5 | 638.8 | 634.4 | 738.3 | 826.6 | 968.7 | 1,136 |
| EBITDA 1 | 230.5 | 246.9 | 128 | 117.3 | 140.3 | 170.5 | 221.1 | 286 |
| EBIT 1 | 215.2 | 232.2 | 94.29 | 82.08 | 101.8 | 130.3 | 173 | 230.6 |
| Net income 1 | 128.3 | 186 | 41.58 | -25.51 | 48.89 | 43.07 | 101.1 | 144.9 |
| Net Debt 1 | -237.8 | -339.1 | -681.9 | -231.8 | -23.81 | -199.5 | -383.5 | -607.7 |
| Reference price 2 | 264.84 | 169.31 | 179.80 | 143.94 | 163.86 | 141.23 | 141.23 | 141.23 |
| Nbr of stocks (in thousands) | 55,289 | 55,524 | 55,832 | 56,027 | 56,291 | 56,436 | - | - |
| Announcement Date | 2/17/22 A | 2/22/23 A | 2/21/24 A | 2/20/25 A | 2/24/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 184.61x | 9.4x | 45.58x | -.--% | 7.97B | |
| 30.92x | 4.2x | 16.3x | 2.39% | 187B | |
| 19.84x | 3.45x | 12.15x | 3.4% | 112B | |
| 17.72x | 0.2x | 12.49x | 0.74% | 61.99B | |
| 29.98x | 7.26x | 18.97x | 1.34% | 48.52B | |
| 36.67x | 3.26x | 11.11x | 2.33% | 46.4B | |
| 38.42x | 1.4x | 12.29x | 0.2% | 33.89B | |
| 30.4x | 5.45x | 17.36x | -.--% | 28.99B | |
| 39.35x | 6.89x | 24.68x | 0.27% | 23.75B | |
| 25x | 3.79x | 13.27x | 1.11% | 22.89B | |
| Average | 45.29x | 4.53x | 18.42x | 1.18% | 57.33B | |
| Weighted average by Cap. | 30.38x | 3.87x | 15.33x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RGEN Stock
- Valuation Repligen Corporation
Select your edition
All financial news and data tailored to specific country editions
